# Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial

> **NCT03391375** · PHASE1 · COMPLETED · sponsor: **EuroVacc Foundation** · enrollment: 49 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **BIOLOGICAL:** DNA-HIV-PT123 & AIDSVAX B/E

## Key facts

- **NCT ID:** NCT03391375
- **Lead sponsor:** EuroVacc Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-15
- **Primary completion:** 2018-01-01
- **Final completion:** 2018-07-31
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2019-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03391375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03391375, "Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03391375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*